Safety and Immunogenicity Study of Recombinant Ricin Toxin A-Chain Vaccine (RVEc™)

NCT01317667 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

FED

Sponsor class

Conditions

Ricin

Interventions

BIOLOGICAL: RVEc

Sponsor

U.S. Army Medical Research and Development Command

Collaborators

[object Object]